Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

15.5K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.5K
Disorders of Leukocytes01:27

Disorders of Leukocytes

1.2K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nursing care of patients with multiple myeloma: a paradigm for the needs of special populations.

Clinical journal of oncology nursing·2002
Same author

Uncommon leukemias: implications for clinical practice.

Seminars in oncology nursing·1990
Same author

Clinical safety and efficacy evaluation of a hydroactive hydrocolloid dressing in the care of cancer patients.

Journal of enterostomal therapy·1989
Same author

A comparative trial of moxalactam plus ticarcillin and clavulanic acid or piperacillin as empiric antibiotic therapy for febrile cancer patients.

Journal of clinical pharmacology·1987
Same author

Systematic assessment and training of sex education for a mentally retarded woman.

Applied research in mental retardation·1985
Same author

Coronary artery disease.

Anesthesiology·1970
Same journal

Boundary Erosion in Oncology Nursing: Psychosocial Consequences and Coping Strategies-A Qualitative Study.

Seminars in oncology nursing·2026
Same journal

Health-Related Quality of Life in Cancer Cachexia: Validation of the Turkish Version of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT).

Seminars in oncology nursing·2026
Same journal

A Dyadic Study of Lived Experiences of Family Stress, Emotional Distress and Family Resilience Among Women With Cancer During Pregnancy and Their Partners.

Seminars in oncology nursing·2026
Same journal

Rapid Reduction in Cancer Worry Through a Mindfulness-based Coping Programme: Evidence from a Randomised Trial with Women Awaiting Biopsy Results.

Seminars in oncology nursing·2026
Same journal

Refining Genomic Integration in Hereditary Breast Cancer: Reflections on Clinical and Nursing Implications.

Seminars in oncology nursing·2026
Same journal

Bridge Symptoms Between Symptom Clusters in Children with Acute Lymphoblastic Leukemia During Maintenance Therapy: A Network Analysis.

Seminars in oncology nursing·2026
See all related articles

Related Experiment Video

Updated: Sep 28, 2025

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.9K

Multiple myeloma

C A Sheridan1

  • 1Department of Nursing, Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, NY 10467, USA.

Seminars in Oncology Nursing
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Multiple myeloma is an incurable blood cancer. Oncology nurses play a vital role in managing symptoms and improving the quality of life for patients with multiple myeloma.

More Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.5K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.2K

Related Experiment Videos

Last Updated: Sep 28, 2025

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

6.9K
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.5K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.2K

Area of Science:

  • Hematology
  • Oncology
  • Nursing Science

Background:

  • Multiple myeloma is a complex hematologic malignancy.
  • Understanding its epidemiology and pathogenesis is crucial for effective management.

Purpose of the Study:

  • To provide a comprehensive review of multiple myeloma.
  • To cover epidemiology, pathogenesis, clinical features, diagnosis, treatment, and nursing management.

Main Methods:

  • Literature review methodology.
  • Inclusion of review articles, research studies, and book chapters on multiple myeloma.

Main Results:

  • Multiple myeloma remains incurable despite therapeutic advances.
  • Patients face chronic and acute symptomatic episodes.

Conclusions:

  • Oncology nurses are essential in managing multiple myeloma symptoms and improving patient quality of life.
  • Early recognition of complications like hypercalcemia and spinal cord compression through nursing assessments is critical.